Global Intermittent Pneumatic Compression (IPC) Devices Market

Intermittent Pneumatic Compression (IPC) Devices Market Outlook 2031:

The global intermittent pneumatic compression (IPC) devices market size was valued at USD 1.05 Billion in 2022 and is projected to reach USD 1.85 Billion by 2031, expanding at a CAGR of 6.5% during the forecast period 2023 - 2031. Increasing prevalence of vascular diseases such as deep vein thrombosis and pulmonary embolism is expected to boost the sales of IPC devices.

An intermittent pneumatic compression (IPC) device, known as a sequential compression device or compression sleeve, is a compressible/inflatable sleeve that is worn on claves/lower legs while convalescing from surgery, injury, pregnancy, or an illness in the hospital and rehab center. The device helps prevent deep vein thrombosis (DVT) and blood clots by keeping blood flowing through blood vessels.

The sleeves inflate with outside air after every minute and deflate again and hence the massage cycle of regulating blood circulation goes on. Hence, the accumulation of blood clots is prevented by the healthy movement of blood.

When the sleeves squeeze, it aids the movement of blood to the heart from the body parts. When the sleeves expand/deflate, the oxygenated blood is directed to pump from the heart to the leg tissues. The process assists to release anticoagulants to prevent blood clots.

IPC devices are majorly used in hospitals where patients have immobility, due to illness or surgery. This inactivity increases the risk of deep vein thrombosis (DVT), which forms blood clots at a rapid pace, especially in limbs. Intermittent pneumatic compression devices suppress pulmonary embolism, DVT lymphedema, and other blood clots. IPC devices are designed to be made portable for general use at home.

IPC devices are a mechanical alternative to medicines for blood clots, where potential side effects are drastic. Internal gear pumps with radial and axial sealing gap compensation are used in IPC medium-pressure pumps.

These pumps are designed for operating pressures up to 250 bar with good overall efficiency, due to particular design features and an effective hydrostatic force balancing. IPC pumps are substantially smaller in exterior dimensions than comparable IPH units, due to a new, volume-optimized involute gearing.

Over the years, the rate of diagnosis of vascular diseases such as deep vein thrombosis and pulmonary embolism surged significantly. This results in the slowing down of blood flow, clumping together of red blood cells, and formation of blood clots. Lymphedema disease is accounting for its major prevalence and causes swelling in soft tissues due to the accumulation of lymph. Intermittent Pneumatic Compression (IPC) devices help to recover from such vascular ailments.

Advancements in medical engineering brought about many groundbreaking innovations in healthcare technology. Novel techniques are designed to make Intermittent Pneumatic Compression (IPC) devices lightweight, portable, and breathable sleeves, eliminating the clumsy air hoses. Such advanced IPC devices eliminate the need for complex electrical cord setups and operate on a 24-hour lithium-ion battery. They are being made disposable, which lowers the cost of the equipment significantly.

Intermittent pneumatic compression devices are manufactured for home use. They are portable enough to be carried anywhere inside the home, in cars, and outdoors. Such portable devices are lightweight and have no tubes and hoses attached to increase the ease of use. These devices provide non-invasive and continuous monitoring of medical parameters. Through connectivity, they provide real-time data/updates to healthcare professionals.

Intermittent Pneumatic Compression (IPC) devices are used by rehabilitation practitioners as an intervention for patients dealing with blood circulatory conditions. The devices are used to prevent/control edema, as it slows down the vascular rehab process. IPC devices are proven to be a highly efficient tool while treating edema.

IPC devices are becoming popular among sports rehab centers, as athletes face injuries such as Exercise-induced muscle damage (EIMD) and delayed onset muscle soreness (DOMS), due to extensive and rigorous physical activities.

Intermittent Pneumatic Compression (IPC) Devices Market Dynamics

Increasing prevalence of vascular diseases

Over the years, the rate of diagnosis of vascular diseases such as deep vein thrombosis and pulmonary embolism surged significantly. This results into slowing down of blood flow, clumping together of red blood cells, and formation of blood clots. Lymphedema disease is accounting for its major prevalence and causes swelling in soft tissues due to the accumulation of lymph. Intermittent Pneumatic Compression (IPC) devices help to recover from such vascular ailments.

Ease of use and portability

Intermittent pneumatic compression devices are manufactured for home use. They are portable enough to be carried anywhere inside a home, in cars, and outdoors. Such portable devices are lightweight and have no tubes and hoses attached to increase the ease of use. These devices provide non-invasive and continuous monitoring of medical parameters. Through connectivity, they provide real-time data/updates to healthcare professionals.

High development cost

Intermittent Pneumatic Compression (IPC) devices account for the high cost of development, as it undergoes various stages such as designing, research and development, clinical trials, regulatory approvals, precision manufacturing, and many more. Several findings reported that there has been an approximately 270% increase in the price of innovative cardiovascular medical devices. It is more expensive than traditional heparin therapy.

IPC devices cost in the range of $1000 to $9000, which outreaches the affordability for end-users, especially in developing regions such as Asia and Africa, due to low purchasing power factor. High cost of Intermittent Pneumatic Compression (IPC) devices curtails sales in the market.

Implementation of Modern Technology

Smart IPC devices use digital technologies and mobiles and computers for remote monitoring of vital medical indications. It features a flexible portable design along with an LCD screen for visibility. It is deployed with additional features such as an automatic compression cycle facility, total blood circulation every hour, detecting and monitoring the patient's therapy cycle, and less vibrations.

A study by the University of Minnesota found that the use of an advanced pneumatic compression device reduced the episodes of skin infections that occur annually in patients with lymphedema by nearly 80 percent.

Scope of Intermittent Pneumatic Compression (IPC) Devices Market Report

The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Intermittent Pneumatic Compression (IPC) Devices Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast
Base Year	2022
Historical Data	2016  & 2021
Forecast Period	2023 - 2031
Segmentation	Medical Condition (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT)), Applications (Home use and Hospital), Distribution Channel (Clinics, Pharmacies, Other offline channels and Online channels)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered	Arjo Huntleigh Bio Compression Systems, Cardinal Health, Currie Medical Specialties, Devon Medical Products, DJO Global, Medline, Mego Afek ltd., ThermoTek, Zimmer Biomet, Breg Inc., Inc. (PlasmaFlow), ManaMed Inc., Encompass Group, LLC.

Intermittent Pneumatic Compression (IPC) Devices Market Segmental Insights

Based on medical condition, the intermittent pneumatic compression (IPC) devices market is divided into deep vein thrombosis (DVT), and pulmonary embolism (PE). The deep vein thrombosis (DVT) segment is expected to grow at a rapid rate during the forecast period, as the risk of DVT can be reduced by giving IPC on the affected muscle. The major area of thrombus formation are the deep and long veins of the calf, thigh, and thrombi that originate there.

DVTs are diagnosed in individuals having abnormal blood clotting physiology or abnormal blood flow in tissues due to limited mobility or a sedentary lifestyle. DVTs are prevented and treated by mechanical devices such as IPC devices. DVT is a common complication of immobilizing the lower limbs after surgery. Mechanical IPC devices lower the sluggish and viscous blood flow, which is usually combined with medications such as anticoagulants heparin and aspirin to reduce clotting of blood

Based on applications, the global intermittent pneumatic compression (IPC) devices market is classified into home-use and hospitals. The home-use segment is expected to grow at a rapid rate during the forecast period, as IPC devices are designed to be portable and medically approved for home use under medical prescription.

An IPC device helps patients to recover from vascular ailments from home. It has features such as a tubeless design, easy button functionality, a visual display, and a rechargeable battery.

Patients usually are prescribed IPC devices for rapid recovery at home after being discharged from a medical surgery. IPC devices are used at home used by geriatric people and individuals recovering from fatigue after long hours of travel. The technology provides support not only for care related to chronic and acute medical conditions at home but also for disease prevention and improving lifestyle choices.

The hospital segment is expected to expand at a significant pace, as the majority of IPC devices are made for hospital use. The devices used in hospitals are not portable, heavy, sophisticated, and operated by medical professionals. Hospitals use IPC devices under various patients’ conditions such as recent surgery, deep vein injury, heavy blood clotting, pregnancy, cancer treatment, and immobility. They are also used after a stroke or to help treat lymphedema.

Based on distribution channel, the global intermittent pneumatic compression (IPC) devices market is classified into clinics, pharmacies, other offline channels, and online channels. The clinic segment is expected to grow at a rapid rate during the forecast period, as hospitals and clinics are legally authorized to offer and sell medical equipment such as IPC devices directly to patients. Medical professionals from clinics prescribe and offer IPC devices according to a patient’s medical condition and requirements.

Some clinics may not sell IPC devices directly to end-user; however, they use a set of intermediates or channel partners to deliver the device. Such channel members include sales agents, medical representatives, doctors, and assistants to doctors. The online channels is expected to expand at a remarkable rate during the forecast period, as it is convenient to order online IPC devices with medical prescription.

Individuals far from a terrestrial pharmacy, the elderly, and disabled individuals benefit from the easy and fast purchasing of medicines online. The operating model of E-pharmacy includes websites and mobile application, which directly links end-users to inventory, which in turn, lowers the cost of medical gadgets such as IPC device.

Intermittent Pneumatic Compression (IPC) Devices Market Regional Outlook

On the basis of regions, the market is categorized as North America, Europe, Asia Pacific, Latin America, and Rest of the World.

North America is segmented into countries such as the US and Canada. The intermittent pneumatic compression (IPC) devices market in North America is expanding and dominating as compared to other regional markets, owing to the established and developed healthcare and medtech industry in the region. Additionally, the presence of a significant number of market participants across the region, especially in the US, is resulting in the growth of the market in the region.

Based on sub-regions, the intermittent pneumatic compression (IPC) devices market in Asia Pacific is categorized as China, Japan, South Korea, India, Australia, and Rest of Asia Pacific. Countries such as China, South Korea, India, and Japan account for a significant share of the market and the market in these countries is projected to expand at a significant CAGR during the forecast period.

Asia Pacific is expected to hold a significant share of the market during the forecast period due to rising investments in the medical devices sector. Increasing government initiatives to manufacture medical device products that are technologically advanced and of high medical grade are expected to fuel the demand for IPC devices in Asia Pacific region.

Key Benefits for Industry Participants & Stakeholders

• In-Depth Analysis of the Intermittent Pneumatic Compression (IPC) Devices Market.
• Historical, Current, and Projected Market Size in Terms of Value.
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on From Intermittent Pneumatic Compression (IPC) Devices Market Performance

Segments

Medical Conditions

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)

Application

• Home Use
• Hospital

Distribution Channel

• Clinics
• Pharmacies
• Other Offline Channels
• Online Channels

Key Market Players Profiled in the Report

• Arjo Huntleigh
• Bio Compression Systems
• Cardinal Health
• Currie Medical Specialties
• Devon Medical Products
• DJO Global
• Medline
• Mego Afek ltd.
• ThermoTek
• Zimmer Biomet
• Breg Inc., Inc. (PlasmaFlow)
• ManaMed Inc.
• Encompass Group, LLC

Competitive Landscape

Key players in the intermittent pneumatic compression (IPC) devices market are Arjo Huntleigh, Bio Compression Systems, Cardinal Health, Currie Medical Specialties, Devon Medical Products, DJO Global, Medline, Mego Afek ltd., ThermoTek, Zimmer Biomet, Breg Inc., Inc. (PlasmaFlow), ManaMed Inc., and Encompass Group, LLC.

These companies are considered as key market players of intermittent pneumatic compression (IPC) devices market, based on their revenue, research & development (R&D) activities in the areas of improving offerings, and regional presence. The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition and many other strategies to cater the increasing demand for intermittent pneumatic compression (IPC) devices.